Trial comparing treatments for Atrial Fibrillation
Official title Anteroposterior Versus Anterolateral Electrode Position for Electrical Cardioversion of Atrial Fibrillation
ClinicalTrials.gov ID: NCT05511389
What this study is testing
- What it's testing
- This study aims to find out which position for the shock pads is more effective at restoring a normal heart rhythm. It also checks if pressing down on the pads helps if the first shock does not work.
- Who it's for
- The study is looking for adults who need a non-urgent procedure to fix atrial fibrillation or atrial flutter.
- What's involved
- Participants will be randomly assigned to have the pads placed either front-to-back or front-to-side. If the first shock does not work, they may also be randomly assigned to have pressure applied to the pads or not.
- Time commitment
- The study involves a single visit for the electrical cardioversion procedure and a heart test (EKG) to check the results.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Consenting adult patients scheduled for non-emergent electrical cardioversion of Atrial Fibrillation or Flutter
You likely can't join if
- Insufficiently anticoagulation for cardioversion as per Canadian Cardiovascular Society guidelines or have not undergone trans-esophageal...
- Anatomic contraindication to anterolateral or anteroposterior placement (e.g. skin conditions or wounds)
The study team makes the final eligibility decision.
Where it is enrolling
- Hamilton, Ontario, Canada
- Toronto, Ontario, Canada
- Québec, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hamilton, Ontario, Canada; Toronto, Ontario, Canada; Québec, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.